CHYM
Earnings in 2 days · May 6, 2026 · After close
Signal
Leaning Bearish1!
Price
1
Move-0.72%Quiet session
Volume
1
Volume0.8× avgNormal activity
Technical
1
TrendRally vs TrendAbove 50D, below 200D
PRICE
Prev Close
22.24
Open
22.31
Day Range21.80 – 22.56
21.80
22.56
52W Range16.17 – 44.94
16.17
44.94
21% of range
VOLUME & SIZE
Avg Volume
4.2M
Float
384.1M
FUNDAMENTALS
P/E Ratio
-5.2x
Not profitable
EPS (TTM)
$-4.27
Div Yield
No dividend
Quick Read
Earnings in 2d · May 6
Trend
RALLY
Price above SMA50, below SMA200
Momentum
BULLISH
price above key MAs · revenue +31% YoY
Valuation
FAIR
P/E not available
Health
STRONG
CR 4.5 · FCF $0.09/sh
Strong Buy
Key MetricsTTM
Market Cap$8.48B
Revenue TTM$2.19B
Net Income TTM-$1.01B
Free Cash Flow$32.11M
Gross Margin85.9%
Net Margin-46.2%
Operating Margin-47.6%
Return on Equity-76.9%
Return on Assets-51.4%
Debt / Equity0.10
Current Ratio4.53
EPS TTM$-2.69

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
46/100
Liquidity
4.53Strong
Leverage
0.10Strong
Coverage
0.0xConcern
ROE
-76.9%Concern
ROIC
-65.5%Concern
Cash
$466MStrong
ANALYST COVERAGE8 analysts
BUY
+35.9%upside to target
L $29.00
Med $30.00consensus
H $30.00
Buy
788%
Hold
113%
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Full report →
Stock Health
Composite Score
5 of 7 signals bullish
8/10
Trend
Trend StateRally (above SMA50, lagging SMA200)
Above SMA 50$21.04 (+5.0%)
Above SMA 200$23.48 (-6.0%)
Technicals
MA AlignmentDeath Cross (50D vs 200D -10.4%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 4.53 — healthy liquidity
Upcoming Events
EEarnings ReportMay 5, 2026
Tomorrow
DEx-Dividend DateAug 2, 2026
In 90 days
Technicals
Market Position
Price Levels
52W High
$44.94+103.5%
SMA 200
$23.48+6.4%
Current
$22.08
SMA 50
$21.04-4.7%
52W Low
$16.17-26.8%
52-Week RangeNear 52-week low
$16.1721th %ile$44.94
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 15 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$1.9B
$1.9B$2.0B
-$11.58
±3%
High6
FY2025
$2.2B
$2.1B$2.2B
+11.5%-$4.57
±1%
High12
FY2026(current)
$2.7B
$2.6B$2.7B
+22.7%$0.17
±30%
High15
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCHYM
Last 3Q
+9.3%avg beat
Beat 2 of 3 quartersMissed 1
-50%
Q3'25
+38%
Q4'25
+40%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Goldman SachsBuy
Dec 1
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Marshall CynthiaDir
$780K
Mar 2
SELL
Britt Christopher RCEO
$1.4M
Jan 9
SELL
Newcomb Matthew SCFO
$280K
Jan 9
SELL
Frankel Adam BGeneral Counsel
$14K
Jan 9
SELL
Frankel Adam BGeneral Counsel
$120K
Jan 8
SELL
Feuille JamesDir
$179K
Dec 16
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Nuveen, LLC
3.5M
2
Pictet Asset Management Holding SA
397K
3
Brown University
205K
4
WHITTIER TRUST CO OF NEVADA INC
193K
5
Y-Intercept (Hong Kong) Ltd
163K
6
HAMILTON LANE ADVISORS LLC
129K
7
U.S. Capital Wealth Advisors, LLC
111K
8
BAXTER BROS INC
106K
News & Activity

CHYM News

20 articles · 4h ago

About

No company information available